Kimberly D Allman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Kent State UniversityMasters, 2014
Publications & Presentations
PubMed
- 52 citationsPatterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.Haris Zahoor, Pedro C. Barata, Xuefei Jia, Allison Martin, Kimberly D Allman
Journal for Immunotherapy of Cancer. 2018-10-17 - 24 citationsA phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe Chaim Ornstein, Laura S. Wood, Brian P. Hobbs, Kimberly D Allman, Allison Martin
Journal for Immunotherapy of Cancer. 2019-05-16
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-6833
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: